Presentation of STAM Mouse Model Research at the 99th Annual Meeting of the Japanese Pharmacological Society
SMC Laboratories is pleased to announce that our research abstract has been accepted for a poster presentation at the 99th Annual Meeting of the Japanese Pharmacological Society, held March 16–18, 2026.
In this presentation, we report the therapeutic efficacy of resmetirom and semaglutide in the STAM mouse model, focusing on the translation from surrogate endpoints to clinically relevant outcome measures.
Through this work, we aim to share insights into translational nonclinical evaluation strategies in the MASH field.
Conference website
https://am.pharmacol.or.jp/jps99/